First human tests begin for experimental drug
NCT ID NCT07090785
Summary
This is the first study in humans for the experimental drug LY4088044. Researchers want to see if it's safe and how the body handles it in 104 healthy volunteers. Participants will receive injections under the skin or into a vein, and researchers will monitor them for side effects and measure drug levels in the blood for up to 92 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Collaborative Neuroscience Network - CNS
NOT_YET_RECRUITINGLos Alamitos, California, 90720, United States
Contact Phone: •••-•••-••••
Contact
-
ICON
NOT_YET_RECRUITINGLenexa, Kansas, 66219, United States
Contact Phone: •••-•••-••••
Contact
-
ICON
RECRUITINGSalt Lake City, Utah, 84124, United States
Contact Phone: •••-•••-••••
Contact
-
ICON Early Phase Services
RECRUITINGSan Antonio, Texas, 78209, United States
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
NOT_YET_RECRUITINGSingapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
-
New Zealand Clinical Research Christchurch
NOT_YET_RECRUITINGChristchurch, 8011, New Zealand
Contact
Conditions
Explore the condition pages connected to this study.